BIOMAT Database Logo BIOMAT Database Logo

The metabolic fate of DL(7-3H)isoprenaline in man and dog. 1969

C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog.
July 1968, Journal of pharmaceutical sciences,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
The metabolic fate of 3H-fenetylline in man.
January 1970, European journal of pharmacology,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
The metabolic fate of diphenylhydantoin in the dog, rat and man.
November 1960, The Journal of pharmacology and experimental therapeutics,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
The metabolic fate of 11-bromo[15-3H]vincamine in man.
January 1985, European journal of drug metabolism and pharmacokinetics,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
Metabolic fate of [14C]-brotizolam in the rat, dog, monkey and man.
March 1986, Arzneimittel-Forschung,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
The fate of (3H)salbutamol in man.
November 1971, The Biochemical journal,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
Approach to the pharmacokinetics of dl-7-3H-noradrenaline.
August 1973, European journal of clinical pharmacology,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
THE FATE OF 1,2-3H CORTEXOLONE IN MAN.
September 1964, Acta endocrinologica,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
The fate of intravenous (3H)glycopyrrolate in man.
May 1974, The Journal of pharmacy and pharmacology,
C D Morgan, and M Sandler, and D S Davies, and M Conolly, and J W Paterson, and C T Dollery
Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog.
February 1975, British journal of pharmacology,
Copied contents to your clipboard!